Fogel, Mark A.Anwar, ShaftkatBroberg, CraigBrowne, LornaChung, TaylorJohnson, TiffanieMuthurangu, VivekTaylor, MichaelValsangiacomo‑Buechel, EmanuelaWilhelm, Carolyn2023-07-102023-07-102022-06-21Fogel MA, Anwar S, Broberg C, et al. Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the use of cardiovascular magnetic resonance in pediatric congenital and acquired heart disease : Endorsed by The American Heart Association. J Cardiovasc Magn Reson. 2022;24(1):37. Published 2022 Jun 21. doi:10.1186/s12968-022-00843-7https://hdl.handle.net/1805/34286Cardiovascular magnetic resonance (CMR) has been utilized in the management and care of pediatric patients for nearly 40 years. It has evolved to become an invaluable tool in the assessment of the littlest of hearts for diagnosis, pre-interventional management and follow-up care. Although mentioned in a number of consensus and guidelines documents, an up-to-date, large, stand-alone guidance work for the use of CMR in pediatric congenital 36 and acquired 35 heart disease endorsed by numerous Societies involved in the care of these children is lacking. This guidelines document outlines the use of CMR in this patient population for a significant number of heart lesions in this age group and although admittedly, is not an exhaustive treatment, it does deal with an expansive list of many common clinical issues encountered in daily practice.en-USAttribution 4.0 InternationalCardiac magnetic resonanceCongenital heart diseasePediatricsChildrenAcquired pediatric heart diseaseArticle